ClinicalTrials.gg
Not yet recruitingNCT07396961Updated Feb 9, 2026

Consistency of ASIS Line vs. Tuffier's Line for Lumbar Level Identification

An observational study in Spinal Anesthesia Evaluation and Lumbar Vertebrae, sponsored by Kangbuk Samsung Hospital. Not yet recruiting at 2 sites in South Korea. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-02-09.

Sponsored by Kangbuk Samsung Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
140
Ages
18 Years to 85 Years
Sex
All
01

Study summary

Tuffier's line is commonly used as a landmark for estimating lumbar vertebral levels during spinal anesthesia. However, its accuracy can vary depending on factors such as age, sex, BMI, and posture. This study evaluates the consistency of an alternative landmark, the "ASIS line" (a line connecting both Anterior Superior Iliac Spines), for identifying lumbar levels in the lateral decubitus position. Researchers will mark both the ASIS line and Tuffier's line on participants and use ultrasound to verify the exact vertebral level where each line crosses the spine. The goal is to determine if the ASIS line provides a more consistent and reliable estimation of lumbar levels compared to Tuffier's line.

02

Conditions studied

  • Spinal Anesthesia Evaluation
  • Lumbar Vertebrae

Keywords

  • vertebral level
  • Ultrasound
  • Tuffier's line
  • ASIS
  • Lateral decubitus position
03

In context

Lead sponsor

Kangbuk Samsung Hospital is the lead sponsor of 63 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients visiting the study centers (Kangbuk Samsung Hospital or St. Vincent's Hospital) who are scheduled for spinal anesthesia or lumbar ultrasound.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 to 85 years
  • Patients scheduled for spinal anesthesia or lumbar ultrasound
  • Participants who voluntarily agreed to participate and provided written

Exclusion criteria

Exclusion Criteria:

  • History of spinal surgery or spinal deformity
  • Infection or wounds at the puncture site
  • Inability to maintain the lateral decubitus position
  • Congenital lumbosacral transitional vertebrae (e.g., sacralized L5 or lumbarized S1)
  • Any other condition deemed unsuitable for the study by the investigator
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
140 participants (estimated)
Patient registry
No

Groups and cohorts

  • Study Cohort

    Adult patients (aged 18-85) scheduled for spinal anesthesia or lumbar ultrasound

    Diagnostic Test: Lumbar Ultrasound & Palpation

Interventions

  • Diagnostic testLumbar Ultrasound & Palpation

    Identification of vertebral levels using Tuffier's line (palpation) and ASIS line, followed by ultrasound verification.

06

What researchers measure

Primary outcomes

  1. Consistency of Vertebral Level Identification (Standard Deviation)

    The specific vertebral level where the ASIS line and Tuffier's line intersect the spine will be identified using ultrasound. The lumbar spine (from L2 upper to S1 upper) is divided into segments (e.g., L2=2, L3=3, L4=4, L5=5, S1=6). The consistency of each method is evaluated by calculating and comparing the standard deviation (SD) of the identified vertebral levels.

    Time frame: Day 1 (Immediately during the ultrasound examination)

Secondary outcomes

  1. Difference in Mean Intersection Level

    Comparison of the mean vertebral levels identified by the ASIS line versus Tuffier's line to determine if there is a significant difference in the average level indicated.

    Time frame: Day 1

  2. Rate of Identification within L4-L5 Interspace

    The percentage of cases where the identified line falls within the target L4-L5 interspace (or within ±1 interspace range).

    Time frame: Day 1

07

Study locations

2 sites
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07396961
Lead sponsor
Kangbuk Samsung Hospital
Responsible party
Sung Hyun Lee (Associate Professor, Kangbuk Samsung Hospital) — Principal investigator
First posted
Feb 9, 2026
Start date
Feb 20, 2026 (estimated)
Primary completion
Feb 20, 2027 (estimated)
Completion
Feb 20, 2028 (estimated)
Last update
Feb 9, 2026

Study contacts

Sung Hyun Lee, MD, PhD
Contact
hoho4321.lee@samsung.com
+82-2-2001-1666

Oversight

Data monitoring committee
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion